Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$446.73 - $548.2 $6.46 Million - $7.93 Million
-14,465 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$478.3 - $607.98 $104,269 - $132,539
-218 Reduced 1.48%
14,465 $6.99 Million
Q3 2020

Nov 13, 2020

BUY
$544.75 - $658.21 $154,164 - $186,273
283 Added 1.97%
14,683 $8.22 Million
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $1.48 Million - $1.93 Million
3,003 Added 26.35%
14,400 $8.98 Million
Q4 2019

Feb 19, 2020

BUY
$274.13 - $376.51 $3,563 - $4,894
13 Added 0.11%
11,397 $4.28 Million
Q3 2019

Nov 05, 2019

BUY
$273.46 - $318.39 $45,941 - $53,489
168 Added 1.5%
11,384 $3.16 Million
Q2 2019

Aug 12, 2019

BUY
$299.6 - $414.82 $10,186 - $14,103
34 Added 0.3%
11,216 $3.51 Million
Q1 2019

May 07, 2019

BUY
$372.08 - $439.57 $88,927 - $105,057
239 Added 2.18%
11,182 $4.59 Million
Q4 2018

Feb 13, 2019

BUY
$335.82 - $403.04 $16,791 - $20,152
50 Added 0.46%
10,943 $4.09 Million
Q3 2018

Nov 13, 2018

BUY
$351.14 - $408.51 $14,396 - $16,748
41 Added 0.38%
10,893 $4.4 Million
Q2 2018

Aug 14, 2018

BUY
$284.6 - $344.99 $27,037 - $32,774
95 Added 0.88%
10,852 $3.74 Million
Q1 2018

May 14, 2018

BUY
$315.82 - $393.78 $8,527 - $10,632
27 Added 0.25%
10,757 $3.7 Million
Q4 2017

Feb 14, 2018

BUY
$358.63 - $469.95 $23,310 - $30,546
65 Added 0.61%
10,730 $4.03 Million
Q3 2017

Nov 13, 2017

BUY
$431.38 - $504.0 $4.6 Million - $5.38 Million
10,665
10,665 $4.77 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Mason Street Advisors, LLC Portfolio

Follow Mason Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mason Street Advisors, LLC with notifications on news.